Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
n/a
Main Authors: | Dimitrios Tsikas, Bibiana Beckmann, Pedro Araujo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-10-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/8/11/311 |
Similar Items
-
Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA
by: Jente Boelaert, et al.
Published: (2016-05-01) -
Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
by: You‐Lin Tain, et al.
Published: (2017-03-01) -
Quality Control in Targeted GC-MS for Amino Acid-OMICS
by: Dimitrios Tsikas, et al.
Published: (2023-08-01) -
Urinary Dimethylamine (DMA) and Its Precursor Asymmetric Dimethylarginine (ADMA) in Clinical Medicine, in the Context of Nitric Oxide (NO) and Beyond
by: Dimitrios Tsikas
Published: (2020-06-01) -
GC-MS Studies on Derivatization of Creatinine and Creatine by BSTFA and Their Measurement in Human Urine
by: Olga Begou, et al.
Published: (2021-05-01)